GlaxoSmithKline News and Research

RSS

Drug company donates bird flu vaccine to World Health Organization

A donation by Swiss drug maker Roche, of enough of its Tamiflu antiviral drug to treat 3 million people against birdflu, could slow the spread of the outbreak among humans, especially in countries too poor to afford their own stockpile.

24 Aug 2005

Drug company disputes claim of new study on antidepressant Paxil

Drug company GlaxoSmithKline (GSK) is disputing claims that its antidepressant Paxil was linked to an increased suicide risk in adults.

23 Aug 2005

Governments should consider stockpiling zanamivir (Relenza) for flu pandemics

Governments should consider stockpiling zanamivir as an anti-influenza agent in their pandemic plans, states a Comment in this week’s issue of The Lancet.

11 Aug 2005

New insight into how protein E75 may control circadian rhythms and metabolic processes

University of Toronto researchers have gained new insight into how a specific protein may control circadian rhythms and metabolic processes, which has implications for treating cholesterol-related diseases.

28 Jul 2005

Biota's potential damages claim against GlaxoSmithKline could be as high as $430 million

Biota Holdings Limited of Melbourne, Australia, has announced its Particulars of Loss and Damage in its suit against GlaxoSmithKline (GSK) for failing to support Biota’s influenza drug, Relenza. The damages assessment was filed with the Victorian Supreme Court and estimates Biota’s losses in the range of $308 million to $430 million.

26 Jul 2005

Potential use of NH neurotransmitters as novel source for psychiatric drugs

Physiologists and medical researchers have long recognized the important endocrine roles played by the pituitary hormones oxytocin (OT) and vasopressin (VP) on peripheral systems in lactation, uterine contraction and urine concentration.

19 Jul 2005

Spontaneous contractions suppressed in late-term rat pregnancy

A long-time aim of obstetrical research has been to find agents that could delay or diminish pre-term labor because even today pre-term birth is a leading cause of infant mortality and morbidity.

19 Jul 2005

FDA fast tracks HIV protease inhibitor from Vertex and GSK

Vertex Pharmaceuticals has announced that its collaborator, GlaxoSmithKline (GSK), has received fast track designation for the HIV protease inhibitor (PI) 640385 (VX-385) from the United States Food and Drug Administration.

19 Jul 2005

Brief course of chemotherapy after surgery should be the new standard of care around the world

A Canadian national clinical trial has found that chemotherapy following surgery for early-stage non-small cell lung cancer significantly improves survival for the disease over just surgery alone.

27 Jun 2005

GlaxoSmithKline announces availability of Paxil CR to U.S. market

GlaxoSmithKline announced today the availability of Paxil CR (paroxetine hydrochloride controlled release) tablets in pharmacies across the United States. Other markets will follow shortly thereafter.

27 Jun 2005

Double whammy of chemo plus surgery extends life for lung cancer patients

Recent research which has shown that chemotherapy can significantly lengthen life in many patients with lung cancer, has meant that doctors, for the first time in decades, have begun making major changes in the treatment of the disease.

23 Jun 2005

Partnership to develop an AIDS vaccine using a promising new technology

GlaxoSmithKline Biologicals (GSK Biologicals) and the International AIDS Vaccine Initiative (IAVI) today announced a public-private partnership to develop an AIDS vaccine using a promising new technology.

21 Jun 2005

First blood test to help predict a patient's risk for ischemic stroke

The U.S. Food and Drug Administration (FDA) has approved the first blood test designed to help predict a patient's risk for ischemic stroke, the most common type of stroke and one of the nation's leading causes of long-term disability affecting approximately 700,000 people per year.

19 Jun 2005

New series of human drug targets available to all researchers

The Structural Genomics Consortium (SGC), an Anglo-Canadian charitable consortium of public and private agencies including Oxford University, announced recently that it has delivered its first 50 human and malaria protein structures into the public domain on budget and two months ahead of schedule.

6 Jun 2005

New vaccine against whooping cough is effective in teens and adults

The Journal of the American Medical Association (JAMA) has announced that a study to be published in the June 22/29 issue found that a new vaccine against whooping cough is effective in teens and adults, carriers of the contagious respiratory disease so dangerous to infants.

3 Jun 2005

Tragic death of 5 year old asthma patient was avoidable and due to complacency of health professionals

At a fatal accident inquiry a sheriff has hit out at the "complacency" of health professionals and a drugs manufacturer over the safety of an asthma inhaler steroid.

25 May 2005

Merck cervical cancer virus vaccine performs well

Drugmaker Merck & Co. Inc. on Thursday said its investigational vaccine against a sexually transmitted virus linked to cervical cancer triggered a stronger immune response in young adolescents than in young women in a late-stage trial.

20 May 2005

Cervical cancer virus vaccine appears very promising

Gardasil, a vaccine created by drugmaker Merck & Co which aims to protect against a sexually transmitted virus linked to cervical cancer, triggered a stronger immune response in young adolescents than in young women in a late-stage trial.

19 May 2005

Clues about how alcoholic behavior is “switched” on

As part of an ongoing effort to understand the biochemical basis of alcohol abuse, scientists at the U.S. Department of Energy’s Brookhaven National Laboratory have published two studies on how modulating receptors for dopamine - a chemical “signaler” in the brain’s reward circuits - affects drinking behavior in mice and rats.

9 May 2005

New cervical cancer drug could be a bestseller

New data released yesterday says that a new vaccine that promises to protect against cervical cancer could offer wider resistance to the disease than previously thought.

5 May 2005